옵션 체인은 다양한 행사가격과 만기일에 대한 Intellia Therapeutics의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Intellia Therapeutics에 대한 시장 심리를 평가합니다..

Intellia Therapeutics (NASDAQ:NTLA) 주식, 옵션 체인

Intellia Therapeutics

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Equities

News

Markets

CPRI

MNPR

NTLA

TSLA

미국 주식 시장은 목요일에 혼조세를 보였다. 나스닥 종합지수는 130포인트 이상 상승한 반면, 다우존스 지수는 0.3% 하락하여 42,374.36으로 마감되었다. S&amp;P 500 지수도 0.2% 상승하여 5,809.86으로 마감했다.

목요일 주목받은 주식: 모노파 테라퓨틱스, 인텔리아 테라퓨틱스, 카프리, 웨스턴 디지털 및 테슬라

ETFs

ACHR

ARKK

AVAV

BLDE

TDOC

VERV

수요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 이 회사의 인상적인 2분기 납품 실적에 힘입은 최근 상승세에도 불구하고 테슬라(NASDAQ:TSLA)의 상당 수의 주식을 매각하여 주목할만한 움직임을 보였다.

아크 인베스트가 예상을 넘는 2분기 배송 실적에도 $3.25백만 규모 테슬라 주식 매도 추가

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

ARKW

COIN

ROKU

수요일에 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 변동성이 큰 시장 속에서 로쿠(NASDAQ:ROKU)와 코인베이스 글로벌(NASDAQ:COIN)에서 상당한 거래를 했다. 이러한 눈에 띄는 거래는 아크의 다양한 ETF가 수행한 일련의 거래의 일부였다.
로쿠 거래

아크 인베스트는 로쿠 $730만의 주식을 매수, 비트코인 하락에 코인베이스 주식을 매각

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

Deep-pocketed investors have adopted a bearish approach towards Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SIRI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Sirius XM Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 44% bearish. Among these notable options, 2 are puts, totaling $73,900, and 7 are calls, amounting to $1,172,700.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $23.0 and $28.0 for Sirius XM Holdings, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Sirius XM Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Sirius XM Holdings's significant trades, within a strike price range of $23.0 to $28.0, over the past month.
<h3>Sirius XM Holdings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835991_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SIRI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$4.3</td>
<td>$3.8</td>
<td>$4.02</td>
<td>$25.00</td>
<td>$1.0M</td>
<td>71</td>
<td>2.5K</td>
</tr>
<tr>
<td>SIRI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.5</td>
<td>$3.2</td>
<td>$3.5</td>
<td>$26.00</td>
<td>$46.2K</td>
<td>1</td>
<td>138</td>
</tr>
<tr>
<td>SIRI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$23.00</td>
<td>$31.2K</td>
<td>7.8K</td>
<td>109</td>
</tr>
<tr>
<td>SIRI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.1</td>
<td>$4.05</td>
<td>$4.1</td>
<td>$23.00</td>
<td>$28.7K</td>
<td>7.8K</td>
<td>229</td>
</tr>
<tr>
<td>SIRI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.84</td>
<td>$2.77</td>
<td>$2.77</td>
<td>$28.00</td>
<td>$27.7K</td>
<td>564</td>
<td>100</td>
</tr>
</tbody>
</table>

<h3>About Sirius XM Holdings</h3>
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service, which offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company operates the service through a handful of geostationary satellites that it owns and operates, but it now offers a streaming SiriusXM option as well. Pandora, which makes up a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants like Spotify, Apple Music, and YouTube Music.
<h3>Where Is Sirius XM Holdings Standing Right Now?</h3>
<ul>
<li>With a volume of 2,023,037, the price of SIRI is down -2.98% at $26.83. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 86 days.</li>
</ul>
<h3>Expert Opinions on Sirius XM Holdings</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $33.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Pivotal Research persists with their Buy rating on Sirius XM Holdings, maintaining a target price of $37. 
&#x2A; An analyst from B of A Securities downgraded its action to Underperform with a price target of $23. 
&#x2A; An analyst from Barrington Research persists with their Outperform rating on Sirius XM Holdings, maintaining a target price of $40. 
&#x2A; An analyst from Benchmark downgraded its action to Buy with a price target of $43. 
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Neutral rating on Sirius XM Holdings with a target price of $23. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Sirius XM Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

SIRI

This Is What Whales Are Betting On Sirius XM Holdings

Deep-pocketed investors have adopted a bullish approach towards MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MELI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for MercadoLibre. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 43% leaning bullish and 16% bearish. Among these notable options, 8 are puts, totaling $340,414, and 22 are calls, amounting to $1,874,803.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1480.0 to $2300.0 for MercadoLibre over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in MercadoLibre's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to MercadoLibre's substantial trades, within a strike price spectrum from $1480.0 to $2300.0 over the preceding 30 days.
<h3>MercadoLibre Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835986_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$523.9</td>
<td>$506.0</td>
<td>$518.53</td>
<td>$2080.00</td>
<td>$518.5K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/08/24</td>
<td>$185.4</td>
<td>$173.5</td>
<td>$180.76</td>
<td>$1910.00</td>
<td>$216.1K</td>
<td style="text-align: right;">26</td>
<td style="text-align: right;">18</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$275.9</td>
<td>$261.1</td>
<td>$271.46</td>
<td>$2060.00</td>
<td>$135.7K</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$123.7</td>
<td>$112.1</td>
<td>$118.2</td>
<td>$2000.00</td>
<td>$130.0K</td>
<td style="text-align: right;">19</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>MELI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$217.0</td>
<td>$209.5</td>
<td>$209.5</td>
<td>$2160.00</td>
<td>$104.7K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
</tr>
</tbody>
</table>

<h3>About MercadoLibre</h3>
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions as of the end of 2023. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Having examined the options trading patterns of MercadoLibre, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>MercadoLibre's Current Market Status</h3>
<ul>
<li>With a trading volume of 105,657, the price of MELI is up by 0.91%, reaching $2073.53.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 1 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for MercadoLibre</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $2640.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on MercadoLibre with a target price of $2480. 
&#x2A; Reflecting concerns, an analyst from Redburn Atlantic lowers its rating to Buy with a new price target of $2800.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MercadoLibre with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

MELI

Unpacking the Latest Options Trading Trends in MercadoLibre

Deep-pocketed investors have adopted a bullish approach towards DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DKNG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for DraftKings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 3 are puts, totaling $243,940, and 9 are calls, amounting to $600,915.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $32.5 to $55.0 for DraftKings over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for DraftKings options trades today is 5089.27 with a total volume of 3,209.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for DraftKings's big money trades within a strike price range of $32.5 to $55.0 over the last 30 days.
<h3>DraftKings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835981_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$7.0</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$55.00</td>
<td>$242.4K</td>
<td>89</td>
<td style="text-align: right;">701</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.35</td>
<td>$39.00</td>
<td>$134.6K</td>
<td>349</td>
<td style="text-align: right;">402</td>
</tr>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$10.8</td>
<td>$10.7</td>
<td>$10.7</td>
<td>$46.00</td>
<td>$102.7K</td>
<td>258</td>
<td style="text-align: right;">206</td>
</tr>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$10.8</td>
<td>$10.7</td>
<td>$10.7</td>
<td>$46.00</td>
<td>$99.5K</td>
<td>258</td>
<td style="text-align: right;">94</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.17</td>
<td>$2.03</td>
<td>$2.17</td>
<td>$38.00</td>
<td>$43.4K</td>
<td>2.1K</td>
<td style="text-align: right;">52</td>
</tr>
</tbody>
</table>

<h3>About DraftKings</h3>
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in 27 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
Having examined the options trading patterns of DraftKings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>DraftKings's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,554,798, with DKNG's price up by 1.95%, positioned at $36.38.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 2 days.</li>
</ul>
<h3>What The Experts Say On DraftKings</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $51.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on DraftKings, maintaining a target price of $52. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on DraftKings, which currently sits at a price target of $48. 
&#x2A; In a cautious move, an analyst from Benchmark downgraded its rating to Buy, setting a price target of $44. 
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $51. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on DraftKings, which currently sits at a price target of $62. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DraftKings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

DKNG

Check Out What Whales Are Doing With DKNG

ETF Store President Nate Geraci suggested that the outcome of the U.S. election could significantly affect the ETF industry, particularly for <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41715056/61-000-is-bitcoin-line-in-the-sand-for-etf-demand-to-remain-steady-says-analyst">crypto-related products</a>.
What Happened: Geraci <a href="https://www.etf.com/sections/features/us-election-could-ripple-through-etf-industry">opined</a> in a blog post for etf.com on Tuesday that, the new administration and Congress will influence key regulatory roles, including the appointment of the SEC chair, which could steer ETF developments.
He identifies three focal areas: crypto ETFs, share class structure and ETF taxation. While the SEC has recently approved spot Bitcoin and Ether ETFs, further crypto innovation under a Kamala Harris-led administration could face regulatory obstacles due to the Biden administration's tough stance on the crypto industry.
ETF taxation is another hot topic, with speculation that the election could revive discussions on removing the tax-deferral advantage for in-kind ETF redemptions, which currently enhances tax efficiency for ETF investors.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41743968/bitcoin-ethereum-etfs-record-over-600-million-net-outflows-ahead-of-election-day">Bitcoin, Ethereum ETFs Record Over $600 Million Net Outflows Ahead Of Election Day</a>
Why It Matters: Over 30 fund companies, including BlackRock, have requested exemptive relief from the SEC to offer an ETF share class of existing mutual funds. The approval of this structure could be influenced by the election outcome, with industry insiders suggesting a Republican-controlled SEC would be more likely to approve.
The ETF industry plays a pivotal role in providing diverse investment products. Potential regulatory changes could reshape how ETFs are structured and taxed, impacting tax efficiency and innovation within the industry.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41741684/veteran-traders-share-presidential-election-crypto-trading-roadmap-predict-heavy-volatilit">Veteran Traders Share &#8216;Presidential Election Crypto Trading Roadmap,&#8217; Predict Heavy Volatility</a></li>
</ul>
Image: Shutterstock

What The US Election Means For The Future Of Crypto ETFs

Ohio's recreational cannabis market has experienced a remarkable rise since its official rollout in August 2024. 
In less than four months, the state has accumulated over $143 million in recreational sales, <a href="https://dam.assets.ohio.gov/image/upload/com.ohio.gov/DCC/DCC_Historical_Sales_Data.pdf">according</a> to the Ohio Department of Commerce Division of Cannabis Control (DCC). 
This rapid growth is powered by the high demand and economic potential of legal cannabis in the Buckeye State.
<h3 class="wp-block-heading">Strong Launch And Steady Demand</h3>
Following Ohio voters' <a href="https://www.benzinga.com/markets/cannabis/23/11/35664155/ohio-legalizes-cannabis-and-overwhelmingly-approves-abortion-rights">approval of Issue 2</a> in 2023, the cannabis market opened with high expectations, allowing adults 21 and over to purchase cannabis products at licensed shops.
Dispensaries across <a href="https://www.benzinga.com/topic/cannabis-ohio">Ohio</a> reported an immediate influx of new customers, with demand remaining strong in major cities like Columbus and Cleveland.
Initial sales data reflects this enthusiasm, with the first month (August) alone generating over $44 million in sales.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="636" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-1024x636.png" alt="" class="wp-image-630811" style="width:536px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-1024x636.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-300x186.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28-768x477.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05121933/Captura-de-pantalla-2024-11-05-a-las-14.19.28.png 1204w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The momentum continued as monthly sales figures climbed steadily. 
September 2024 recorded nearly $54.7 million, while October sales surged to $76.3 million. By November, cumulative sales reached $143 million, underscoring the market's exponential growth. Growth between October and November reached an astonishing 47%.
This steady increase is expected to contribute significantly to Ohio's tax revenue, supported by the state's 10% tax on recreational cannabis purchases.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-">Village Farms Is Only Cannabis Operator Selected To Represent Weed Industry At DEA Rescheduling Hearing</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a></li>
</ul>
<h3 class="wp-block-heading">Expansion Opportunities For Operators</h3>
The swift uptake in Ohio's recreational market has attracted <a href="https://www.benzinga.com/money/multi-state-operators">multi-state operators</a> (MSOs) looking to capitalize on the state's burgeoning cannabis sector.
These MSOs are scaling up to meet consumer demand and expand their footprint within the state. With robust monthly sales, Ohio's cannabis industry presents substantial opportunities for businesses and investors aiming to establish a presence in this growing market.
Since the launch of adult-use sales, Ohio dispensaries have sold over 16,000 pounds of cannabis plant material. In addition to recreational sales, Ohio's established medical cannabis program continues to perform steadily, with medical patients driving consistent demand. 
The average price for manufactured cannabis products, such as edibles and concentrates, reached $29.21 in the last week of October. With 124 dual-use dispensaries authorized to serve both recreational and medical consumers, Ohio's cannabis infrastructure is well-positioned to support <a href="https://www.benzinga.com/markets/cannabis/24/10/41279057/ohios-recreational-cannabis-soars-98-million-in-revenue-within-just-two-months">further market growth</a> and meet the needs of its expanding customer base.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40189647/trulieve-touts-third-consecutive-quarter-of-revenue-growth-narrows-q2-net-loss-97-yoy-launches-c">Trulieve Touts Third Consecutive Quarter Of Revenue Growth, Narrows Q2 Net Loss 97% YoY, Launches Cannabis Sales In Ohio</a></li>
</ul>
Cover: <a href="https://pixabay.com/es/photos/cleveland-ohio-ciudad-urbano-1888370/">Cleveland</a> in Pixabay

Cannabis

Retail Sales

Ohio's Cannabis Market Surges, Reaching $143M In Just 4 Months

WIIM

ZCAR

Zoomcar Holding shares are trading higher after the company reported a major expansion of its customer support team.

Prediction markets like Polymarket and Kalshi have <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41635149/2024-election-odds-on-polymarket-kalshi-show-trump-will-win-why-they-might-be-wrong">surged in popularity</a> during the <a href="https://www.benzinga.com/topic/2024-election">2024 election cycle</a>. Here&#8217;s all you need to know about the betting markets on Election Day as the U.S. elects a new president, either Donald Trump or Kamala Harris.
A Preface: Bettors on Polymarket, Kalshi, and other websites can continue betting even after the polls close. This is different than, say, sports betting where bets are locked after the game starts.
The betting odds will constantly update as votes are counted—favorable partial results for Trump will shift the odds in his column positively, and vice versa. As the race nears being called, the odds will converge on the winner.
The U.S. election could be called on Election Day—or it could take several weeks if a close tally requires recounts. Bettors can bet on the race at any time until the outcome is resolved.
Polymarket Policy: Polymarket <a href="https://polymarket.com/event/presidential-election-winner-2024?tid=1730829736678">lays</a> out its procedure for determining the outcome of its presidential market.
&#8220;This Presidential market resolves when the Associated Press, Fox, and NBC all call the election for the same candidate. In the unlikely event that doesn't happen, the market will remain open until inauguration and resolve to whoever gets inaugurated,&#8221; the website reads.
Kalshi Policy: Kalshi&#8217;s market is <a href="https://kalshi.com/markets/pres/presidential-elections">resolved</a> when the candidate is inaugurated.
&#8220;This market resolves when a candidate (or another representative of their party) is inaugurated as President for the term beginning January 20, 2025,&#8221; its rules read. &#8220;You can cash out of your position at any point in time.&#8221;
Why it Matters: Election night may present challenges such as confusion and misinformation. Bettors are encouraged to familiarize themselves with market rules before placing bets.
Several <a href="https://www.benzinga.com/news/24/11/41698607/kamala-harris-ready-if-trump-decides-to-falsely-declare-victory-we-are-prepared-to-respond">corroborating sources indicate</a> that Trump will prematurely declare victory on election night before all votes are counted. The Trump campaign <a href="https://www.benzinga.com/news/20/11/18202190/trump-declares-victory-ahead-of-results-from-key-states">acted similarly in 2020</a> in its loss to Joe Biden. Bettors should understand that while early results could indicate the direction of the race, it will ultimately not be resolved until the requirements of Polymarket and Kalshi are met.
According to reports, Kamala Harris's campaign and Democratic Party officials anticipate a <a href="https://www.benzinga.com/news/24/11/41698607/kamala-harris-ready-if-trump-decides-to-falsely-declare-victory-we-are-prepared-to-respond">premature victory declaration</a> by Trump in the 2024 election and are reportedly preparing a swift response. The Trump campaign <a href="https://www.benzinga.com/news/20/11/18202190/trump-declares-victory-ahead-of-results-from-key-states">took a similar approach</a> in 2020 during its loss to Joe Biden.
Bettors should be aware that while early results may indicate the potential direction of the race, the final outcome will not be determined until the conditions set by Polymarket and Kalshi are fulfilled.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41748843/trump-holds-edge-in-betting-markets-on-election-day-while-experts-call-tight-race-for-harris">Trump Holds Edge In Betting Markets On Election Day, While Experts Call Tight Race For Harris</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Politics

How Late Can You Bet On The US Election Through Polymarket, Kalshi? Everything You Need To Know

Trading Ideas

Hawaiian Electric Shares Halted Pending News

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining around 1% on Tuesday.
The Dow traded up 0.96% to 42,197.88 while the NASDAQ rose 1.26% to 18,408.47. The S&amp;P 500 also rose, gaining, 1.03% to 5,771.80.
Check This Out: <a href="https://www.benzinga.com/news/24/11/41741538/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 1.8% on Tuesday.
In trading on Tuesday, energy shares rose by just 0.3%.
Top Headline
Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) posted downbeat results for its third quarter
The company reported third-quarter adjusted earnings per share of $1.37 missing the street view of $1.41. Yum! Brands reported a 4% increase in same-store sales for Taco Bell in the U.S., and a 9% unit growth for KFC International. The company's quarterly revenues of $1.826 billion missed the analyst consensus of $1.899 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Bionomics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) shares shot up 170% to $0.5189 after the company announced it secured an AUS$1 million milestone payment from Carina Biotech for its BNC101 oncology program, with the potential to earn up to AUS$118 million.</li>
<li>Shares of Vimeo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) got a boost, surging 44% to $6.91 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares were also up, gaining 33% to $2.43 after the company highlighted data showing the potential of inflammasome inhibition to protect pancreatic islet beta cells and attenuate progression from obesity to insulin resistance and type 2 diabetes.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Marqeta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) shares dropped 40% to $3.55 after the company reported worse-than-expected Q3 sales results. Also, multiple firms downgraded their respective ratings on the company and lowered their respective price targets.</li>
<li>Shares of Verrica Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) were down 41% to $0.8499 following downbeat quarterly results.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) was down, falling 18% to $11.19 after the company announced third-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $71.70 while gold traded up 0.2% at $2,750.20.
Silver traded up 0.4% to $32.725 on Tuesday, while copper rose 0.7% to $4.4645.
Euro zone
European shares closed mostly higher today. The eurozone's STOXX 600 rose 0.06%, Germany's DAX gained 0.57% and France's CAC 40 rose 0.48%. Spain's IBEX 35 Index rose 0.29%, while London's FTSE 100 fell 0.14%.
Spain's consumer confidence indicator declined by 4.6 points to a reading of 84.8 in September.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan's Nikkei 225 gaining 1.11%, Hong Kong's Hang Seng Index gaining 2.14%, China's Shanghai Composite Index gaining 2.32% and India's BSE Sensex gaining 0.88%.
Economics
<ul>
<li>The trade deficit in the U.S. increased to $84.4 billion in September, recording the highest level since April 2022, and above market estimates of a $84.1 billion gap, versus a revised $70.8 billion gap in August.</li>
<li>The ISM services PMI rose to 56 in October, recording the highest reading since Aug. 2022. </li>
<li>The S&amp;P Global composite PMI rose to 54.1 in October compared to 54.0 in September.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41743859/top-3-consumer-stocks-that-may-keep-you-up-at-night-this-quarter">Top 3 Consumer Stocks That May Keep You Up At Night This Quarter</a></li>
</ul>

Earnings

Eurozone

Commodities

BNOX

VMEO

VRCA

ZVSA

Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings

This year&#8217;s <a href="https://www.benzinga.com/markets/esg/24/05/39012013/noaa-meteorologists-predict-aggressive-hurricane-season-what-it-means-for-home-depot-generac-other-s">hurricane season </a>is a deadly one for the eastern and Gulf Coast of the U.S. Several companies and ETFs could be affected by another tropical storm nearing the Gulf Coast.
The Storm: Tropical Storm Rafael, the 17th named storm of the 2024 season, formed in the Caribbean, <a href="https://www.nbcnews.com/weather/hurricanes/tropical-storm-rafael-forms-expected-hurricane-rcna178632">according</a> to NBC.
The storm passed by Jamaica on Tuesday. It is expected to strengthen into a hurricane on Tuesday near the Cayman Islands and pass over Western Cuba. From there, it will likely weaken into a tropical storm before making landfall near New Orleans. The path may change drastically before impacting the U.S.
The heaviest rain of up to 10 inches is expected in Jamaica.
Market Impacts: With a projected path in the Gulf of Mexico, Rafael could disrupt offshore oil and gas production, which could impact companies operating there.
Potentially affected stocks include major energy companies like Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), and Occidental Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>), and ETFs like SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) and Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>).
Storms in the Gulf of Mexico can also disrupt refining operations, which could impact refiners such as Marathon Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>), Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) and Valero Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>).
Construction companies like Vulcan Materials Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) and Martin Marietta Materials Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) might benefit from increased demand for repairs and rebuilding.
Recent extreme weather activity is linked to climate change. Hurricanes, which will become even more frequent over time, may encourage homeowners to purchase home generators. Generac Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) is the largest producer of home generators in the U.S.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41746843/bond-market-fear-gauge-soars-to-1-year-high-ahead-of-us-election-results-bond-vigil">Bond Market Fear Gauge Soars To 1-Year High Ahead Of US Election Results: &#8216;Bond Vigilantes Have Been Voting Early&#8217;</a></li>
</ul>
Photo: Tropical Storm Rafael, 11.5.2024. Courtesy NOAA/Public Domain

Sector ETFs

GNRC

Tropical Storm Rafael Could Make US Landfall: 11 Stocks, ETFs To Watch

SPPL

SIMPPLE Australia And Mode Technology To Showcase Advanced Robotic Cleaning Solutions And Software Platform At New Zealand Cleaning Expo On November 6-7

In the current market session, Lennox Intl Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) stock price is at $601.00, after a 0.61% decrease. However, over the past month, the company's stock increased by 2.48%, and in the past year, by 58.07%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1730835070_0.png" alt="Past Year Chart" />

<h3>Lennox Intl P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 26.68 in the Building Products industry, Lennox Intl Inc. has a higher P/E ratio of 28.72. Shareholders might be inclined to think that Lennox Intl Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730835070_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Lennox Intl

AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) has outperformed the market over the past 15 years by 10.77% on an annualized basis producing an average annual return of 22.43%. Currently, AutoZone has a market capitalization of $51.50 billion. 
Buying $100 In AZO: If an investor had bought $100 of AZO stock 15 years ago, it would be worth $2,140.90 today based on a price of $3046.35 for AZO at the time of writing.
<h3>AutoZone's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835035_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 15 Years Ago Would Be Worth $2,100 Today

ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) has outperformed the market over the past 10 years by 9.93% on an annualized basis producing an average annual return of 20.84%. Currently, ASML Holding has a market capitalization of $267.40 billion. 
Buying $100 In ASML: If an investor had bought $100 of ASML stock 10 years ago, it would be worth $666.33 today based on a price of $673.07 for ASML at the time of writing.
<h3>ASML Holding's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730835030_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASML

Here's How Much $100 Invested In ASML Holding 10 Years Ago Would Be Worth Today

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Gold Royalty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) with a Buy and lowers the price target from $5.75 to $5.5.

Price Target

Analyst Ratings

GROY

HC Wainwright & Co. Maintains Buy on Gold Royalty, Lowers Price Target to $5.5

On Monday, Fidelity National Information Services, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41709529/fis-reports-strong-third-quarter-2024-results-and-raises-full-year-outlook" rel="noreferrer noopener">third-quarter revenue</a> of $2.57 billion, up 3% year over year, topping the analyst consensus of $2.56 billion. Adjusted&nbsp;EPS of $1.40 beat the analyst consensus of $1.29.
The company expects fiscal 2024 revenue of $10.14 billion &#8211; $10.17 billion (prior $10.12 billion &#8211; $10.17 billion) and adjusted EPS of $5.15 &#8211; $5.20 (prior $5.03 &#8211; $5.11).
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41745824/short-squeeze-globalfoundries-stock-soars-on-q3-earnings-beat-strong-q4-outlook" rel="noreferrer noopener">Short Squeeze &#8211; GlobalFoundries Stock Soars On Q3 Earnings Beat, Strong Q4 Outlook</a>
Multiple analysts rerated the stock after the print. RBC Capital analyst Daniel Perlin maintained Fidelity National Info with an Outperform and raised the <a href="https://www.benzinga.com/quote/FIS/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $95 to $104</a>.
KeyBanc analyst Alex Markgraff remained Sector Weight on Fidelity National Info. Goldman Sachs analyst Will Nance reiterated a Buy on Fidelity National Info with a price target of $100, up from $97.
RBC Capital: Perlin highlighted FIS&#8217; recent performance, noting strength in core banking sales and operating leverage in capital markets. Banking segment adjusted revenue grew by 3% year-over-year to $1.71 billion, with an adjusted EBITDA margin of 45.2%, supported by cost-saving efforts and an increasing proportion of recurring revenue, up 6% year-over-year. The recent acquisition of Dragonfly, which offers liquidity management and fraud prevention for complex commercial clients, enhances FIS&#8217; digital offerings and opens cross-selling opportunities with banks not yet using FIS&#8217; core services.
The Capital Markets segment posted 7% adjusted revenue growth, reaching $730 million, with a 49.9% EBITDA margin. This was attributed to a favorable revenue mix and operational leverage. Management anticipates ongoing margin expansion in the segment, driven by increased recurring revenue and a boost in cross-selling activity across the enterprise, which rose 20% year-to-date.
KeyBanc: Markgraff observed that FIS reported better-than-expected third-quarter results and raised its full-year guidance. However, the increase was primarily due to reduced interest expenses and added Worldpay EMI contributions rather than core operational growth. Adjusted revenue in Banking grew 3% year-over-year, driven by steady recurring revenue. Capital Markets adjusted revenue also rose by 7%, reflecting substantial operating leverage and an advantageous revenue mix.
Despite an upbeat revenue beat, Markgraff noted that higher capital expenditures—partly from vendor pricing pressures—dampened immediate market response to the results. The outlook suggests strong momentum, particularly in Capital Markets, though Banking growth is expected to settle closer to the lower to midpoint of its projected range.
Goldman Sachs: Nance noted that FIS outperformed the S&amp;P with a 67 basis point rise, as investors seemed reassured by consistent performance and reaffirmed medium-term targets. Despite anticipated increases in third-party vendor costs impacting capital expenditures, management expressed confidence in maintaining cash flow in 2025. While Worldpay is no longer central to FIS&#8217; strategy, its EMI continues positively impacting EPS. Operationally, FIS saw strong execution with several key customer wins in the Asia-Pacific region, reinforcing confidence in its execution.
Looking ahead, Nance views FIS as a reliable, defensively positioned investment with moderate revenue growth and steady EPS growth, enhanced by capital returns and efficient margin management. He raised the price target, reflecting peer valuation adjustments driven by FIS&#8217; continued positive performance trajectory.
Price Action: FIS stock is down 3.21% at $86.82 at last check Tuesday.
Image: Shutterstock by PopTika
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41748807/thomson-reuters-q3-earnings-legal-corporate-segments-enjoy-revenue-boost-as-ceo-highlights-ai-inves" target="_blank" rel="noreferrer noopener">Thomson Reuters Q3 Earnings: Legal, Corporate Segments Enjoy Revenue Boost As CEO Highlights AI Investment</a></li>
</ul>

Analyst Color

Reiteration

Fidelity National Information Services' Banking, Capital Markets Growth Drive Optimism, Analysts Say

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) with a Hold.

Needham Reiterates Hold on Verrica Pharmaceuticals

Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) stock is trading lower on Tuesday. Bank of America expects the stock to experience some volatility after the company&#8217;s striking machinists voted to approve the plane maker&#8217;s <a href="https://www.benzinga.com/markets/equities/24/11/41736062/boeing-workers-end-seven-week-strike-by-accepting-new-contract-with-major-pay-increases">latest labor contract proposal</a>.
What To Know: The International Association of Machinists and Aerospace Workers (IAM) voted to ratify Boeing&#8217;s labor proposal on Monday, with 59% of the votes in favor of the deal.
In a new note to clients on Tuesday, BofA analyst Ronald Epstein said recently appointed Boeing CEO Kelly Ortberg &#8220;added another check to the &#8216;Boeing Turnaround&#8217; list&#8221; by bringing an end to what had been a 53-day strike. Although Epstein is optimistic about the news, he cautioned that a return to normal operations could still take a while. 
&#8220;While the strike ending and workers returning to the shopfloor is a meaningful step in the right direction, ramping back up will take time,&#8221; the BofA analyst said. 
Epstein pumped the brakes on Boeing&#8217;s production ramp, noting that some employees will have to go through retraining sessions after returning to work by Nov. 12.
The offer included a 38% wage increase over four years, enhanced retirement contributions and improved health benefits. Union members also gained flexibility in receiving their one-time $12,000 ratification bonus, with options to allocate it toward their paycheck, 401(k) or a combination of the two.
&#8220;While the full impact of the strike and how quickly production restarts remain to be determined we leave our estimates unchanged and maintain our Neutral rating. However, we do expect to see some volatility in Boeing&#8217;s share price,&#8221; the analyst said.
Related Link: <a href="https://www.benzinga.com/trading-ideas/technicals/24/11/41712908/palantir-q3-earnings-on-deck-as-cathie-wood-cuts-stake">Palantir Q3 Earnings On Deck As Cathie Wood Cuts Stake</a>
BA Price Action: At the time of writing, Boeing shares were down 2.05% at $151.94, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Shutterstock

Movers

Boeing Stock Is Trading Lower, Analyst Sees Volatility Ahead: What's Going On?

Wedbush analyst Nick Setyan reiterates Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Outperform and maintains $390 price target.

WING

Wedbush Reiterates Outperform on Wingstop, Maintains $390 Price Target

alab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) reported better-than-expected third-quarter <a href="https://www.benzinga.com/quote/ALAB/earnings">EPS and sales on Monday</a>.
Astera Labs reported quarterly earnings of 23 cents per share which beat the analyst consensus estimate of 17 cents per share. The company reported quarterly sales of $113.09 million which beat the analyst consensus estimate of $97.44 million.
&#8220;Astera Labs delivered strong Q3 results, setting our fifth consecutive quarterly revenue record and grew 47% versus the previous quarter,&#8221; said Jitendra Mohan, Astera Labs&#8217; Chief Executive Officer. &#8220;Our business has now entered a new growth phase with multiple product families ramping across AI platforms based upon both third-party GPUs and internally developed AI accelerators. With expanding product portfolio including the new Scorpio Fabric Switches, we are cementing our position as a critical part of AI connectivity infrastructure, delivering increased value to our hyperscaler customers, and unlocking additional multi-year growth trajectories for Astera.&#8221;
Astera Labs said it sees fourth-quarter revenue of $126 million to $130 million and adjusted earnings of 25 cents to 26 cents per share.
Astera Labs shares jumped 38.7% to trade at $96.60 on Tuesday.
These analysts made changes to their price targets on Astera Labs following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60a3a5a849aa07000157ebd9/tom-o'malley">Barclays analyst Tom O&#8217;Malley</a> maintained Astera Labs with an Overweight and raised the price target from $70 to $87.</li>
<li>Craig-Hallum analyst Richard Shannon maintained the stock with a Buy and raised the price target from $75 to $105.</li>
<li>Deutsche Bank analyst Ross Seymore maintained Astera Labs with a Buy and boosted the price target from $60 to $100.</li>
<li>J<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59f1c1bdefacff0001706787/harlan-sur">P Morgan analyst Harlan Sur</a> maintained the stock with an Overweight and raised the price target from $70 to $110.</li>
<li>Stifel analyst Tore Svanberg maintained Astera Labs with a Buy and boosted the price target from $80 to $100.</li>
<li>Morgan Stanley analyst Joseph Moore maintained Astera Labs with an Overweight and raised the price target from $74 to $94.</li>
<li>Roth MKM analyst Suji Desilva maintained the stock with a Buy and raised the price target from $80 to $105.</li>
</ul>
Considering buying ALAB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="573" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-1024x573.png" alt="" class="wp-image-631048" style="width:692px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-1024x573.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/05134431/image-35.png 1192w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41746021/this-ebay-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday">This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday</a></li>
</ul>

ALAB

These Analysts Boost Their Forecasts On Astera Labs After Upbeat Results

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on NTLA stock, giving a Buy rating today. Mani Foroohar has given his Bu...

Intellia Therapeutics: Promising Phase 2 Results and Growth Potential Justify Buy Rating

Citi analyst David Lebowitz lowered the firm's price target on Intellia Therapeutics (NTLA) to $19 from $25 and keeps a Neutral rating on the share...

Intellia Therapeutics price target lowered to $19 from $25 at Citi

David Lebowitz, an analyst from Citi, maintained the Hold rating on Intellia Therapeutics (NTLA – Research Report). The associated price target is ...

Intellia Therapeutics' NTLA-2002: Hold Rating Amid Competitive Challenges and Safety Concerns

Intellia Therapeutics: Lower Stock Price On HAE Data Presents A Buying Opportunity

Intellia Therapeutics ( ($NTLA) ) has provided an announcement. Intellia Therapeutics has announced promising Phase 2 results for NTLA-2002, a CRIS...

Intellia Therapeutics Advances with Promising Phase 2 Results

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2024 Update

Warning: NTLA is at high risk of performing badly

JonesTrading analyst Debanjana Chatterjee has maintained their bullish stance on NTLA stock, giving a Buy rating on October 25. Debanjana Chatterje...

Intellia Therapeutics: Positive Outlook and Buy Rating Amid Promising Data for ATTR-CM Treatment

Data Underwhelms - Intellia's Cash, Data And Competition Are A Challenging Story

ALNY

ARKB

ARKF

ARKG

ARKQ

ARKX

BCRX

BEAM

CRSP

HOOD

IONS

PATH

PLTR

RBLX

REGN

RXRX

SHOP

TKPHF

Press Releases

Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2024 Earnings and Company Updates

Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting

Health Care

Intellia Therapeutics to Present New Clinical Data from the Phase 1 Study of nexiguran ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis at the 2024 AHA Scientific Sessions

Intellia Therapeutics Announces Initiation of HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast

Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

Comments

Intellia Therapeutics

Intellia Therapeutics (NTLA) 옵션

Intellia Therapeutics (NASDAQ:NTLA) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌